Key result
Among people living with HIV aged 35-65, the prevalence of elevated blood pressure was 16%, and a 10-15 year duration on ART was associated with increased odds of elevated blood pressure.
Why the study?
Antiretroviral therapies have improved survival in people living with HIV but resulted in emerging non-communicable diseases, including elevated blood pressure, particularly in Sub-Saharan Africa.
Cross-Sectional (n=247)
No
Among people living with HIV in Rwanda, increasing duration on ART and having a stressful job are associated with higher odds of elevated blood pressure, while physical activity and coping with HIV status are protective.
Answers are grounded in this paper and cite their sources.
16% HTN prevalence in Rwandan PLHIV supports routine BP screening in HIV clinics; leaves open ART-specific risks pending prospective data.
The survival rate among People living with HIV has globally increased due to access to Antiretroviral therapies (ARTs). However, ARTs in turn resulted in emerging NCDs, including elevated blood pressure, where the Sub-Saharan Africa (SSA) is the Epicenter. The overall prevalence of Hypertension in Rwanda is 15.9% with expected increase to 17.78 in 2025. This study aimed at assessing the prevalence and associated factors of elevated blood pressure among adult people living with HIV attending Kabutare district hospital in the Southern Province, Rwanda.
No takes yet. Share an insight, caveat, or question.
BERNARD et al. (2023) conducted a cross-sectional in HIV and elevated blood pressure (n=247). Duration on antiretroviral therapy (10-15 years) vs. Duration on ART <5 years was evaluated on Elevated blood pressure (AOR 40.57, 95% CI 3.19-51.78, p=0.004). Among people living with HIV aged 35-65, the prevalence of elevated blood pressure was 16%, and a 10-15 year duration on ART was associated with increased odds of elevated blood pressure.
Synapse has enriched 10 related papers. Consider them for comparative context: